肿瘤研究与临床
腫瘤研究與臨床
종류연구여림상
CANCER RESEARCH AND CLINIC
2010年
9期
604-606
,共3页
冯璐%胡波%李梅%王朝晖%裴笑月%吕申
馮璐%鬍波%李梅%王朝暉%裴笑月%呂申
풍로%호파%리매%왕조휘%배소월%려신
肠肿瘤%X射线修复交叉互补基因1%免疫组织化学
腸腫瘤%X射線脩複交扠互補基因1%免疫組織化學
장종류%X사선수복교차호보기인1%면역조직화학
Intestinal neoplasms%X-ray repair cross complementing gene 1%Immunohistochemistry
目的 探讨大肠癌XRCC1基因表达的临床病理意义.方法 免疫组织化学法检测107例大肠癌、25例癌旁黏膜与36例正常大肠黏膜的XRCC1表达,分析其与临床病理特征的关系.结果 XRCC1在大肠癌和癌旁黏膜的阳性表达率分别为87.9%(94/107)和84.0%(21/25),均明显高于正常大肠黏膜[27.8%(10/36)](P=0.000,P=0.000);大肠癌中,XRCC1的阳性表达率在低分化组为44.4%(4/9),明显低于中分化组和高分化组的94.8%(50/58)(P=0.000)和87.5%(35/40)(P=0.015);XRCC1表达与患者性别、年龄、肿瘤发生部位、浸润深度及淋巴转移均无明显相关关系(P>0.05).结论 监测XRCC1表达可能有助于大肠癌的诊断.
目的 探討大腸癌XRCC1基因錶達的臨床病理意義.方法 免疫組織化學法檢測107例大腸癌、25例癌徬黏膜與36例正常大腸黏膜的XRCC1錶達,分析其與臨床病理特徵的關繫.結果 XRCC1在大腸癌和癌徬黏膜的暘性錶達率分彆為87.9%(94/107)和84.0%(21/25),均明顯高于正常大腸黏膜[27.8%(10/36)](P=0.000,P=0.000);大腸癌中,XRCC1的暘性錶達率在低分化組為44.4%(4/9),明顯低于中分化組和高分化組的94.8%(50/58)(P=0.000)和87.5%(35/40)(P=0.015);XRCC1錶達與患者性彆、年齡、腫瘤髮生部位、浸潤深度及淋巴轉移均無明顯相關關繫(P>0.05).結論 鑑測XRCC1錶達可能有助于大腸癌的診斷.
목적 탐토대장암XRCC1기인표체적림상병리의의.방법 면역조직화학법검측107례대장암、25례암방점막여36례정상대장점막적XRCC1표체,분석기여림상병리특정적관계.결과 XRCC1재대장암화암방점막적양성표체솔분별위87.9%(94/107)화84.0%(21/25),균명현고우정상대장점막[27.8%(10/36)](P=0.000,P=0.000);대장암중,XRCC1적양성표체솔재저분화조위44.4%(4/9),명현저우중분화조화고분화조적94.8%(50/58)(P=0.000)화87.5%(35/40)(P=0.015);XRCC1표체여환자성별、년령、종류발생부위、침윤심도급림파전이균무명현상관관계(P>0.05).결론 감측XRCC1표체가능유조우대장암적진단.
Objective To explore the clinicopathological value of X-ray repair cross complementing gene 1(XRCC1) expression in colorectal carcinoma. Methods The XRCC1 gene expression in 107 cases of colorectal carcinomas, 25 cases of adjacent mucosa and 36 cases of normal colorectal mucosa was detected immunohistochemically, and the correlation between the expression and clinicopathological factors was analyzed. Results The positive rates of XRCC1 expression in colorectal carcinoma and adjacent mucosa,87.8 % (94/107) and 84.0 % (21/25) respectively, were significantly higher than that in the normal colorectal mucosa [27.8 %(10/36) (P=0.000, P =0.000)]. In colorectal carcinoma, the positive rate of XRCC1 expression in the group of poor differentiation [44.4 % (4/9)] was significantly lower than that in the groups of moderate and well differentiation [94.8 % (50/58)(P=0.000) and 87.5 %(35/40) (P=0.015)], while the positive rate of XRCC1 expression was not related to sex, age, location, infiltration depth and lymph node metastasis (P >0.05). Conclusion The results indicated that XRCC 1 protein can be used as a marker to diagnose colorectal carcinoma.